Photodynamic diagnosis is of increasing interest for diagnosis in oncology.
It is based on a more intense incorporation of a fluorescent dye in rumour
s compared to normal tissue. As a feasibility study we investigated the eff
ectiveness of oral application of 5-aminolevulinic acid for photodynamic di
agnosis of human primary mammary tumours. The study included 16 patients wi
th palpable breast tumours. Aminolevulinic acid was administered at a conce
ntration of 40 mg kg(-1) bodyweight 150-420 min prior to tumourectomy. Intr
aoperatively blue light (405 nm) was applied to the operation site. Section
s of the excised tumour and some lymph nodes were prepared and analysed wit
h a fluorescent microscope. All primary mammary tumour tissues showed signi
ficantly higher fluorescence intensity than surrounding normal mammary tiss
ue. Fluorescence of the mammary tumours could also be discriminated macrosc
opically and intraoperatively. Fluorescence intensity in nonmetastatic lymp
h node tissue was higher in 2 out of 3 patients than in primary tumour tiss
ue. By photodynamic diagnosis using aminolevulinic acid we were able to rel
iably distinguish primary mammary tumours from normal mammary tissue micros
copically and macroscopically in all our patients. We suggest that photodyn
amic diagnosis with aminolevulinic acid for breast tumours should be furthe
r investigated and developed for intraoperative use and may well be a simpl
e tool for better intraoperative diagnosis and recognition of tumour margin
s. We hypothesize that lymph node metastasis of breast tumours will not be
detectable by this method. (C) 2001 Cancer Research Campaign http://www.bjc
ancer.com.